These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. In vitro stimulation of lymphocytes of donors seronegative for Epstein-Barr virus by preparations of inactivated Epstein-Barr virus. Chang RS, Spina CA. J Infect Dis; 1976 Jun; 133(6):676-80. PubMed ID: 180190 [Abstract] [Full Text] [Related]
9. Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes. Klein E, Masucci MG. Springer Semin Immunopathol; 1982 Jun; 5(1):63-73. PubMed ID: 6314570 [No Abstract] [Full Text] [Related]
10. EBV antigens in lymphocytes of patients with exudative tonsillitis, infectious mononucleosis and Hodgkin's disease. Veltri RW, McClung JE, Sprinkle PM. Int J Cancer; 1978 Jun 15; 21(6):683-7. PubMed ID: 78913 [Abstract] [Full Text] [Related]
11. Immortalization of human lymphocytes by Epstein-Barr virus. Miller G. Yale J Biol Med; 1982 Jun 15; 55(3-4):305-10. PubMed ID: 6295007 [Abstract] [Full Text] [Related]
13. Regions of the EBV genome involved in latency and lymphocyte immortalization. Miller G. Prog Med Virol; 1984 Jun 15; 30():107-28. PubMed ID: 6087408 [No Abstract] [Full Text] [Related]
14. Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies. Einhorn L, Steinitz M, Yefenof E, Ernberg I, Bakacs T, Klein G. Cell Immunol; 1978 Jan 15; 35(1):43-58. PubMed ID: 202404 [No Abstract] [Full Text] [Related]